Reuters: Regulatory News: RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

RPT-BRIEF-Emergent Biosolutions to expand clinical trial of TRU-016 and rituximab Apr 5th 2013, 11:17 Fri Apr 5, 2013 7:17am EDT April 5 (Reuters) - April 5 (Reuters) - Emergent Biosolutions Inc : * To expand front line CLL clinical trial of TRU-016 and rituximab based on strong patient enrollment and encouraging early clinical data * Source text for Eikon * Further company coverage

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions